SPERIRX Trademark

Trademark Overview

On Wednesday, January 22, 2020, a trademark application was filed for SPERIRX with the United States Patent and Trademark Office. The USPTO has given the SPERIRX trademark a serial number of 88770005. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 29, 2022. This trademark is owned by SperiTX Holdings LLC. The SPERIRX trademark is filed in the Insurance & Financial Services category with the following description:

Pharmaceutical benefit management services
sperirx

General Information

Serial Number88770005
Word MarkSPERIRX
Filing DateWednesday, January 22, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 29, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 2, 2020

Trademark Statements

Pseudo MarkSPERI RX
Goods and ServicesPharmaceutical benefit management services
Translation of Words in MarkThe English translation of the word "SPERI" in the mark is "YOU HOPE"

Classification Information

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, January 27, 2020
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSperiTX Holdings LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressHouston, TX 77024
Party NameSperiTX Holdings LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressHouston, TX 77024

Trademark Events

Event DateEvent Description
Sunday, September 11, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, September 11, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sunday, September 11, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 29, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 29, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, February 1, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 28, 2022SOU EXTENSION 3 GRANTED
Friday, January 28, 2022SOU EXTENSION 3 FILED
Friday, January 28, 2022SOU TEAS EXTENSION RECEIVED
Friday, July 30, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 28, 2021SOU EXTENSION 2 GRANTED
Wednesday, July 28, 2021SOU EXTENSION 2 FILED
Wednesday, July 28, 2021SOU TEAS EXTENSION RECEIVED
Saturday, January 30, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 28, 2021SOU EXTENSION 1 GRANTED
Thursday, January 28, 2021SOU EXTENSION 1 FILED
Thursday, January 28, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, July 28, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 2, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 2, 2020PUBLISHED FOR OPPOSITION
Wednesday, May 13, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, April 23, 2020ASSIGNED TO LIE
Thursday, April 16, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 15, 2020EXAMINER'S AMENDMENT ENTERED
Wednesday, April 15, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, April 15, 2020EXAMINERS AMENDMENT E-MAILED
Wednesday, April 15, 2020EXAMINERS AMENDMENT -WRITTEN
Tuesday, April 14, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 14, 2020NON-FINAL ACTION E-MAILED
Tuesday, April 14, 2020NON-FINAL ACTION WRITTEN
Monday, April 13, 2020ASSIGNED TO EXAMINER
Thursday, April 9, 2020ASSIGNED TO EXAMINER
Monday, January 27, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, January 25, 2020NEW APPLICATION ENTERED

Related Keywords

sperirx services management benefit pharmaceutical